ABSTRACT Seventeen children with unilateral hyperlucent lungs were referred for investigation. Of the 11 who had a referring diagnosis of possible Macleod's syndrome only two were shown to have post-viral bronchiolitis. Three of the 11 had conditions that required surgical treatment and a further two with bronchiectasis were treated medically. To avoid confusion we suggest that Macleod's syndrome is reserved exclusively for children with post-viral bronchiolitis. Radioisotopic regional lung function studies were useful in the investigation of the subjects from three points of view. Firstly, they distinguished children with primary perfusion abnormalties and normal ventilation, secondly, they defined the extent of altered respiratory function, and thirdly, they were able to distinguish compensatory emphysema from congenital lobar emphysema. As bronchography and bronchoscopy may be hazardous in small children with poor respiratory reserve, such regional studies may be useful in indicating which patients do not require further invasive investigation.
Of the many causes of unilateral hyperlucent lung in children, congenital lobar emphysema and foreign body inhalation are among the most common. In general neither of these conditions is difficult to diagnose and the affected lung, or lobe, is usually hyperinflated. There is, however, a small group of children with hyperlucent lungs in whom the diagnosis is not immediately apparent. Unilateral hyperlucent lungs which are normal or small in size are occasionally seen on radiographs in children who present with longstanding respiratory symptoms. Macleod's or Swyer-James syndrome' 2 presents in this way and is now believed to follow respiratory infections such as measles, 3 adenovirus,4 and mycoplasma.3 5 Bronchograms show poor filling of the peripheral bronchi and histologically the bronchi and bronchioles show evidence of chronic inflammatory changes. Some clinicians nevertheless prefer to use the term Macleod's syndrome simply to describe the radiographic appearances and do not imply any aetiology.
Over the past three years 17 children with unilateral hyperlucent lungs have been referred to us for investigation. In many of these children the aetiological diagnosis was uncertain at the time of referral; 11 were referred with a possible diagnosis of Macleod's syndrome. We describe here the results of our investigations and suggest a line of investigation for children presenting in this way.
Methods
The age of patients, history, presenting symptoms and signs, chest radiograph appearances, and initial diagnoses are shown in table 1 . Seven children were known to have congenital heart disease but it was not clear whether their respiratory symptoms and radiographic appearances were related entirely to this or whether they had additional pulmonary disease. Taking the group as a whole the diagnosis of Macleod's syndrome had been considered at some time in 11 children. At the time of referral, four of these children had small hyperlucent lungs, six had lungs of normral size, and one (patient 12) had a large hyperlucent lung which had appeared of normal size previously.
All children had chest radiographs and fluoroscopy and underwent regional lung function studies. These were carried out using nitrogen-13. Both bolus inhalation and bolus injection studies were carried out.6 The distribution of gas and blood throughout both lung fields was determined. The clearance of gas from the lungs after bolus Regional lung function studies showed that in all cases except one (case 14) the peak counts in both inhalation and infusion studies suggested that there was reduced gas and blood reaching the hyperlucent areas in comparison to the other areas. In case 14 the hyperlucent area received more gas and blood than the other areas. This child was subsequently shown to have partial left lower lobe collapse not evident on chest radiograph and thus had compensatory emphysema.
Three children (patients 7, 8 , and 17) showed normal rates of clearance of gas from all regions of both lungs after inhalation and infusion, despite the reduction in peak counts in the hyperlucent areas. All had abnormal pulmonary vascular anatomy-unilateral peripheral pulmonary artery stenosis (patient 7), pulmonary valve stenosis (patient 8), and absent pulmonary artery (patient 17). Thus these children had hyperlucent lungs which were relatively underperfused but had normal ventilatory function. Bronchoscopy and bronchography were therefore not necessary as their symptoms and radiographic appearances could be related entirely to their congenital heart disease.
Nine patients (2-6, 9, 10, 12, and 13) had delayed clearance of gas from the hyperlucent lung or area only. One Three patients (patients 9, 10, and 11) had lobectomies for congenital lobar emphysema and would have had this treatment whether or not regional studies and bronchography had been carried out.
Nevertheless both surgeon and anaesthetist had the benefit of knowing the function of the other lung and lobes. In patients 9 and 10 this was normal but in patient 11 the opposite main bronchus was stenosed. Three other children, all referred as Macleod's syndrome, underwent surgery. One had a tracheal cyst (patient 12) and had been wheezing since birth. Another (patient 2) underwent right middle and right lower lobe lobectomies because of recurrent pneumonia. Both lobes showed changes consistent with post-viral bronchiolitis. The third (patient 5) had a granuloma removed from the left main bronchus. Before surgery this child's chest radiograph had shown that the left lung was small and hyperlucent. This appearance returned to normal after surgery. All children who underwent surgery responded favourably. Two children had bronchiectasis. In patient 16, regional function studies and bronchography suggested bilateral disease, not evident from the chest radiograph. The site of pathology is clearly important in planning physiotherapy. The child with partial left lower lobe collapse underwent physiotherapy and is now well.
Apart from the child with endocardial fibroelastosis who died, the remaining children were managed conservatively.
Discussion
This study emphasises the variety of causes of unilateral hyperlucent lungs. Of the 11 children referred with a diagnosis of possible Macleod's syndrome post-viral bronchiolitis was the final diagnosis in only two and regional studies suggested that one of these had bilateral disease. As some of these children had surgically treatable conditions and others had abnormal pulmonary vasculature only, we feel that the terms "Macleod's syndrome" and "Swyer-Jones syndrome" should be reserved only for children in whom other causes of respiratory symptoms have been ruled out. Investigation for many children meant not only a change in diagnosis but a significant change in treatment. Patients 5, 12 , and 16 for example had been wheezing for some time before being referred.
Regional studies were useful initial investigations for three reasons. Firstly they distinguished children with unequal pulmonary perfusion in the absence of primary lung disease. Several forms of congenital heart disease other than branch pulmonary stenosis are associated with unequal lung vascularity.7 8 Although the distribution of ventilation favoured the well-perfused lung, the ventilatory turnover on both sides was normal. Previous studies with 99mTechnetium and 133Xenon9 10 have shown similar findings in children with unilateral pulmonary artery and recent studies in newborn animals have shown that when the pulmonary artery supply is interrupted to one lung, that lung fails to grow normally, remaining abnormally small." Thus the results of the ventilation scan in the three children with primary perfusion abnormalities suggest that the under-perfused regions were small in comparison to the other regions. Secondly, regional studies were useful in identifying children with bilateral disease. Congenital lobar emphysema usually affects only one lobe of one lung'2 but occasionally the presence of bilateral disease may not be appreciated, as in patient 11 in this series. Abnormal variations in bronchial calibre were seen on fluoroscopy at bronchography Nitrogen-13 was used in this study because it was available to us and because we were interested in evaluating its usefulness. Technetium-99m and Krypton-81m for perfusion and ventilation studies respectively are more readily available. As it is now possible to measure the rate of clearance of 81"Kr from the lungs, information about the distribution of pulmonary blood flow and ventilation in children with lungs of unequal size should be more easily obtainable using a combination of these isotopes.
This study has shown that a significant proportion of children referred to us with hyperlucent lungs had treatable disorders and therefore merited careful investigation. To avoid confusion we suggest that Macleod's syndrome is reserved exclusively for children with post-viral bronchiolitis and should not be used as a blanket diagnosis for unilateral hyperlucent lungs for which there is no obvious aetiology. If regional studies are available to the clinician they may be helpful in indicating children who do not need further in-vasive investigation and in defining the extent of altered respiratory function.
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